 Vitaly Kheyfets
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 16 | 2025 | 1910 | 2.710 |
Why?
| | Ventricular Dysfunction, Right | 9 | 2025 | 238 | 2.620 |
Why?
| | Pulmonary Artery | 19 | 2024 | 1086 | 2.550 |
Why?
| | Ventricular Function, Right | 14 | 2025 | 285 | 2.250 |
Why?
| | Heart Ventricles | 12 | 2025 | 788 | 1.890 |
Why?
| | Vascular Resistance | 6 | 2025 | 375 | 1.560 |
Why?
| | Computer Simulation | 10 | 2024 | 978 | 1.420 |
Why?
| | Pulmonary Circulation | 7 | 2024 | 429 | 1.280 |
Why?
| | Magnetic Resonance Imaging, Cine | 9 | 2021 | 193 | 1.250 |
Why?
| | Ventricular Remodeling | 5 | 2025 | 266 | 1.220 |
Why?
| | Models, Cardiovascular | 7 | 2025 | 198 | 1.080 |
Why?
| | Microvessels | 2 | 2025 | 88 | 0.950 |
Why?
| | Vascular Remodeling | 3 | 2025 | 193 | 0.930 |
Why?
| | Microcirculation | 1 | 2025 | 149 | 0.920 |
Why?
| | Coronary Circulation | 1 | 2025 | 143 | 0.920 |
Why?
| | Hemodynamics | 8 | 2025 | 1113 | 0.860 |
Why?
| | Coronary Vessels | 1 | 2025 | 248 | 0.830 |
Why?
| | Hydrodynamics | 4 | 2025 | 45 | 0.780 |
Why?
| | Regional Blood Flow | 5 | 2021 | 474 | 0.740 |
Why?
| | Pulmonary Embolism | 1 | 2023 | 226 | 0.680 |
Why?
| | Stress, Mechanical | 5 | 2025 | 485 | 0.680 |
Why?
| | Ventilators, Mechanical | 1 | 2020 | 58 | 0.660 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 80 | 0.650 |
Why?
| | Fibrosis | 3 | 2021 | 552 | 0.610 |
Why?
| | Magnetic Resonance Angiography | 3 | 2017 | 240 | 0.590 |
Why?
| | Patient-Specific Modeling | 2 | 2017 | 41 | 0.550 |
Why?
| | Algorithms | 5 | 2020 | 1704 | 0.530 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.470 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.470 |
Why?
| | Bandages | 1 | 2014 | 37 | 0.440 |
Why?
| | Arterial Pressure | 4 | 2020 | 126 | 0.420 |
Why?
| | Blood Flow Velocity | 5 | 2019 | 413 | 0.420 |
Why?
| | Patients | 1 | 2015 | 175 | 0.420 |
Why?
| | Gravitation | 1 | 2013 | 18 | 0.410 |
Why?
| | Cellulose | 1 | 2013 | 39 | 0.410 |
Why?
| | Materials Testing | 1 | 2014 | 356 | 0.390 |
Why?
| | Ventricular Pressure | 2 | 2024 | 48 | 0.390 |
Why?
| | Drug Carriers | 1 | 2013 | 128 | 0.380 |
Why?
| | Stroke Volume | 7 | 2022 | 612 | 0.370 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4295 | 0.360 |
Why?
| | Wound Healing | 1 | 2014 | 331 | 0.360 |
Why?
| | Hypertension | 1 | 2020 | 1295 | 0.350 |
Why?
| | Imaging, Three-Dimensional | 2 | 2025 | 580 | 0.350 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2607 | 0.340 |
Why?
| | MicroRNAs | 1 | 2017 | 692 | 0.340 |
Why?
| | Cardiac Catheterization | 6 | 2021 | 530 | 0.340 |
Why?
| | Anti-Infective Agents | 1 | 2013 | 255 | 0.340 |
Why?
| | Polymers | 1 | 2014 | 490 | 0.330 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5757 | 0.310 |
Why?
| | Biomarkers | 2 | 2023 | 4149 | 0.270 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2018 | 267 | 0.260 |
Why?
| | Animals | 11 | 2025 | 36940 | 0.250 |
Why?
| | Humans | 36 | 2024 | 137585 | 0.240 |
Why?
| | Vascular Stiffness | 4 | 2017 | 494 | 0.230 |
Why?
| | Male | 21 | 2025 | 67762 | 0.220 |
Why?
| | Mice | 6 | 2025 | 17787 | 0.220 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2023 | 145 | 0.210 |
Why?
| | Forecasting | 2 | 2024 | 389 | 0.210 |
Why?
| | Child | 12 | 2024 | 21935 | 0.200 |
Why?
| | Fontan Procedure | 1 | 2024 | 180 | 0.190 |
Why?
| | Blood Pressure | 2 | 2021 | 1786 | 0.190 |
Why?
| | Perfusion Imaging | 2 | 2019 | 58 | 0.190 |
Why?
| | Lung | 2 | 2022 | 4060 | 0.180 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2021 | 51 | 0.180 |
Why?
| | Female | 18 | 2025 | 73304 | 0.180 |
Why?
| | Hypoxia | 3 | 2023 | 1112 | 0.180 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2021 | 135 | 0.170 |
Why?
| | Predictive Value of Tests | 3 | 2021 | 2031 | 0.170 |
Why?
| | Proof of Concept Study | 1 | 2020 | 78 | 0.170 |
Why?
| | Transcriptome | 2 | 2024 | 971 | 0.170 |
Why?
| | Tacrolimus | 1 | 2021 | 199 | 0.160 |
Why?
| | Respiratory Mechanics | 1 | 2020 | 67 | 0.160 |
Why?
| | Cardiac Output | 2 | 2017 | 165 | 0.160 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 1040 | 0.160 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1774 | 0.160 |
Why?
| | Ventricular Function, Left | 2 | 2020 | 534 | 0.150 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2021 | 752 | 0.150 |
Why?
| | Sensitivity and Specificity | 3 | 2022 | 1946 | 0.150 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 383 | 0.140 |
Why?
| | Thermodilution | 1 | 2017 | 13 | 0.140 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 69 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.140 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 108 | 0.140 |
Why?
| | Alzheimer Disease | 1 | 2023 | 560 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 3 | 2024 | 3566 | 0.130 |
Why?
| | Lung Diseases | 1 | 2023 | 767 | 0.130 |
Why?
| | Aortic Diseases | 1 | 2017 | 119 | 0.130 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 7 | 0.120 |
Why?
| | Prospective Studies | 5 | 2021 | 7604 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 915 | 0.120 |
Why?
| | Aorta, Thoracic | 1 | 2017 | 267 | 0.120 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2018 | 382 | 0.110 |
Why?
| | Adhesiveness | 1 | 2014 | 20 | 0.110 |
Why?
| | Rats | 1 | 2023 | 5647 | 0.110 |
Why?
| | Oxygen Consumption | 1 | 2017 | 696 | 0.110 |
Why?
| | Aorta | 1 | 2017 | 417 | 0.110 |
Why?
| | Contrast Media | 1 | 2017 | 467 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2017 | 3284 | 0.110 |
Why?
| | Administration, Intravaginal | 1 | 2013 | 16 | 0.100 |
Why?
| | Compliance | 1 | 2013 | 49 | 0.100 |
Why?
| | Blood Circulation | 1 | 2013 | 41 | 0.100 |
Why?
| | Bioengineering | 1 | 2013 | 18 | 0.100 |
Why?
| | Aneurysm, Ruptured | 1 | 2013 | 35 | 0.100 |
Why?
| | Severity of Illness Index | 5 | 2019 | 2828 | 0.100 |
Why?
| | Solutions | 1 | 2013 | 168 | 0.100 |
Why?
| | Aneurysm | 1 | 2013 | 31 | 0.100 |
Why?
| | Child, Preschool | 5 | 2021 | 11074 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2024 | 198 | 0.100 |
Why?
| | Fibroblasts | 3 | 2023 | 996 | 0.100 |
Why?
| | Epithelium | 1 | 2013 | 313 | 0.090 |
Why?
| | Pressure | 1 | 2013 | 225 | 0.090 |
Why?
| | Surface Properties | 1 | 2013 | 413 | 0.090 |
Why?
| | Adolescent | 7 | 2021 | 21513 | 0.090 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2013 | 140 | 0.090 |
Why?
| | Retrospective Studies | 5 | 2021 | 15657 | 0.090 |
Why?
| | Swine | 1 | 2014 | 775 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.090 |
Why?
| | Vagina | 1 | 2013 | 187 | 0.090 |
Why?
| | Time Factors | 5 | 2021 | 6828 | 0.090 |
Why?
| | Case-Control Studies | 4 | 2019 | 3556 | 0.080 |
Why?
| | Middle Aged | 7 | 2024 | 33479 | 0.080 |
Why?
| | Heart Failure | 1 | 2023 | 2236 | 0.080 |
Why?
| | Skin | 1 | 2014 | 752 | 0.080 |
Why?
| | Precision Medicine | 1 | 2013 | 429 | 0.080 |
Why?
| | Signal Transduction | 1 | 2021 | 5079 | 0.070 |
Why?
| | Endothelial Cells | 2 | 2023 | 785 | 0.070 |
Why?
| | Disease Progression | 1 | 2015 | 2757 | 0.070 |
Why?
| | Elasticity | 2 | 2019 | 197 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2021 | 5131 | 0.060 |
Why?
| | Proteomics | 2 | 2023 | 1111 | 0.060 |
Why?
| | Myocardium | 2 | 2021 | 1002 | 0.060 |
Why?
| | Age Factors | 3 | 2019 | 3295 | 0.060 |
Why?
| | Infant | 4 | 2021 | 9465 | 0.060 |
Why?
| | Cohort Studies | 1 | 2015 | 5742 | 0.060 |
Why?
| | Vena Cava, Inferior | 1 | 2024 | 71 | 0.050 |
Why?
| | Amyloidogenic Proteins | 1 | 2023 | 16 | 0.050 |
Why?
| | tau Proteins | 1 | 2023 | 90 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 111 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 382 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2023 | 278 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 16 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 298 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2023 | 220 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 499 | 0.040 |
Why?
| | Young Adult | 4 | 2019 | 13209 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 984 | 0.040 |
Why?
| | Myocytes, Cardiac | 1 | 2024 | 526 | 0.040 |
Why?
| | Suture Techniques | 1 | 2020 | 122 | 0.040 |
Why?
| | Dimensional Measurement Accuracy | 1 | 2019 | 13 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 452 | 0.040 |
Why?
| | Aged | 4 | 2022 | 23961 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2023 | 706 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 688 | 0.040 |
Why?
| | Exercise Tolerance | 1 | 2020 | 279 | 0.040 |
Why?
| | Numerical Analysis, Computer-Assisted | 1 | 2018 | 19 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 152 | 0.040 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 21 | 0.040 |
Why?
| | Finite Element Analysis | 1 | 2018 | 75 | 0.040 |
Why?
| | Rheology | 1 | 2018 | 92 | 0.040 |
Why?
| | Viscosity | 1 | 2018 | 92 | 0.030 |
Why?
| | Prognosis | 2 | 2017 | 4030 | 0.030 |
Why?
| | Genomics | 1 | 2023 | 795 | 0.030 |
Why?
| | Printing, Three-Dimensional | 1 | 2018 | 95 | 0.030 |
Why?
| | Aftercare | 1 | 2019 | 208 | 0.030 |
Why?
| | Phantoms, Imaging | 1 | 2018 | 152 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 431 | 0.030 |
Why?
| | Shear Strength | 1 | 2017 | 67 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2017 | 62 | 0.030 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 842 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 653 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 322 | 0.030 |
Why?
| | Adult | 3 | 2024 | 37929 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2017 | 272 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 849 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2023 | 4193 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1153 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 816 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 2085 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1316 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 314 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3196 | 0.030 |
Why?
| | Macrophages | 1 | 2022 | 1547 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 341 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 554 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2017 | 810 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2013 | 51 | 0.020 |
Why?
| | Angiography | 1 | 2013 | 207 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 1972 | 0.020 |
Why?
| | Risk Factors | 2 | 2017 | 10388 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2015 | 956 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2013 | 233 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2837 | 0.020 |
Why?
| | Kinetics | 1 | 2013 | 1670 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2691 | 0.020 |
Why?
| | Risk Assessment | 1 | 2013 | 3457 | 0.010 |
Why?
|
|
Kheyfets's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|